Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Ossium Health Secures $125 Million BARDA Contract to Advance Bone Marrow Bank for Radiological and Nuclear Emergencies
Sep 30, 2024
Contract Type
contract
San FranciscoBiotechnologyHealth Care
Description
Ossium Health has signed a $21 million contract with the Biomedical Advanced Research and Development Authority (BARDA) to advance the company’s bone marrow for national emergency preparedness. The contract has the potential to reach a total value of $125 million with additional options spanning five years. The partnership is focused on accelerating the processing of Ossium’s proprietary Hematopoietic Progenitor Cell (HPC) Marrow product, conducting clinical studies, and expanding Ossium’s network of bone marrow banks across the United States.
Company Information
Company
Ossium Health
Location
80 Tehama St
San Francisco, California, United States
About
Ossium Health is a bioengineering company that leverages its proprietary organ donor bone marrow banking platform to develop stem cell therapies for patients with life-threatening blood and immune diseases. Founded in 2016, the company is led by Kevin Caldwell, its CEO, Co-Founder & President, and Erik Woods, its Chief Science Officer, Co-Founder & EVP. Ossium Health is an FDA-Registered Tissue Bank, is accredited by the Commission on Office Laboratory Accreditation (COLA), and its laboratory is certified under the Clinical Laboratory Improvement Amendment (CLIA).